Top accelerator startups

Startups14,448Programs29

14,448 startups · 29 programs

Grannus Therapeutics

Grannus Therapeutics is a preclinical biotech startup, focused on developing novel first-in-class Hsp90𝛽-selective inhibitors for the treatment of multiple solid tumors.

WebsitePlug and Play page

Why it ranks

How the rank works
1signal of 100 · rising 1
  • went through Plug and PlayProgram · this site+1

A sum of public facts, not a judgement and not investment advice.

Competitors

OtherEris BiotechShared: solid tumor, small molecule, therapeuticYC W24Salt Lake CityStartup →OtherInactiveGerostate AlphaShared: developing novel, therapeuticYC S18San FranciscoStartup →OtherOrigami Therapeutics, Inc.Shared: developing novel, small molecule, therapeuticYC W22San DiegoStartup →OtherSift BiosciencesShared: solid tumor, class, novelPlug and PlayUnited StatesStartup →OtherThe Bland CompanyShared: biotech startup, proteinMassChallenge UK 2025United KingdomStartup →
Companies closest to Grannus Therapeutics
Company
Eris BiotechShared: solid tumor, small molecule, therapeuticYC W24ActiveOther
Gerostate AlphaShared: developing novel, therapeuticYC S18InactiveOther
Origami Therapeutics, Inc.Shared: developing novel, small molecule, therapeuticYC W22ActiveOther
Sift BiosciencesShared: solid tumor, class, novelPlug and Play Not statedOther
The Bland CompanyShared: biotech startup, proteinMassChallenge UK 2025Not statedOther

Adjacent

OtherDiapin TherapeuticsShared: developing novel, therapeutic, classPlug and PlayUnited StatesStartup →AIOxford Cancer AnalyticsShared: cancer treatment, focused, proteinPlug and PlayUnited KingdomStartup →OtherBahto BiosciencesShared: small molecule, therapeutic, treatmentPlug and PlayUnited StatesStartup →OtherKyomeiShared: biotech startupMassChallenge Switzerland 2025United KingdomStartup →AIChemT BiotechnologyShared: small moleculeMassChallenge Switzerland and UK 2026SingaporeStartup →
Companies next to Grannus Therapeutics
Company
Diapin TherapeuticsShared: developing novel, therapeutic, classPlug and Play Not statedOther
Oxford Cancer AnalyticsShared: cancer treatment, focused, proteinPlug and Play Not statedAI, Data
Bahto BiosciencesShared: small molecule, therapeutic, treatmentPlug and Play Not statedOther
KyomeiShared: biotech startupMassChallenge Switzerland 2025Not statedOther
ChemT BiotechnologyShared: small moleculeMassChallenge Switzerland and UK 2026Not statedAI

Also from Plug and Play

All of Plug and Play
AISecuraAIA Princeton-based startup helping highly regulated industries, such as healthcare, safely deploy AI by automating AI security and governance.Plug and PlayUnited StatesStartup →AIMango MedicalFoundation models for planning orthopedic surgeryYC W26San FranciscoStartup →AIHypercubicAgentic AI for Mainframe Operations and ModernizationYC F25San FranciscoStartup →AIIndustrialMind.aiThe AI manufacturing engineer that turns drawings into production-ready decisions - 10x faster, proven at Siemens and Fortune 500 factoriesAntler 2025USStartup →AIXatomsXatoms utilizes AI and quantum chemistry to accurately predict 3D models of photocatalytic structures, aiding in cleaning polluted waters across the globe.Plug and PlayCanadaStartup →AIEloquent AIThe AI Operator for Financial ServicesYC X25San FranciscoStartup →
Company
SecuraAIA Princeton-based startup helping highly regulated industries, such as healthcare, safely deploy AI by automating AI security and governance.2 programsNot statedAI
Mango MedicalFoundation models for planning orthopedic surgeryteam of 32 programsActiveAI
HypercubicAgentic AI for Mainframe Operations and Modernizationteam of 3on 3 Glyph sourcesActiveAI, Devtools
IndustrialMind.aiThe AI manufacturing engineer that turns drawings into production-ready decisions - 10x faster, proven at Siemens and Fortune 500 factories2 programsNot statedAI
XatomsXatoms utilizes AI and quantum chemistry to accurately predict 3D models of photocatalytic structures, aiding in cleaning polluted waters across the globe.2 programsNot statedAI
Eloquent AIThe AI Operator for Financial Servicesteam of 52 programsActiveAI

Programs

Programs Grannus Therapeutics went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About Grannus Therapeutics

By focusing on a specific isoform of the Hsp90 chaperone protein, Grannus Therapeutics aims to overcome the toxicity challenges faced by previous pan-inhibitors, leading to more effective and targeted cancer treatments. Their pipeline of first-in-class small molecule inhibitors is designed to deliver potent anti-tumor efficacy without the dose-limiting side effects associated with traditional Hsp90 inhibitors. These compounds show promise in treating various solid tumors, including ovarian, triple-negative breast, prostate, and pancreatic cancers. With the potential for combination therapies with existing cancer treatments, such as chemotherapy and PARP inhibitors, Grannus Therapeutics is at the forefront of advancing oncology research and improving patient outcomes."

Category
Other
Location
United States
Checked
7h ago

Grannus Therapeutics: questions

Which accelerators did Grannus Therapeutics go through?

Grannus Therapeutics is listed by Plug and Play.

Where is Grannus Therapeutics based?

Grannus Therapeutics lists United States as its location on Plug and Play's page.